期刊文献+

主动脉内球囊反搏术在脓毒性休克中的临床应用 被引量:2

Clinical Application of Intra-aortic Balloon Pump in Septic Shock
下载PDF
导出
摘要 目的:分析主动脉内球囊反搏术在脓毒性休克中的临床应用。方法:选取本院收治的62例脓毒性休克患者并按随机数字表法分为对照组和观察组,各31例患者。对照组患者采用脓毒症指南规范抗休克方法治疗,观察组患者在规范抗休克基础加用主动脉内球囊反搏术治疗。对比2组患者治疗后血压、心率、尿量的变化,及不良事件的发生情况。结果:观察组治疗后血压、心率、尿量改善明显优于对照组(P<0.05);观察组治疗后不良事件的总发生率(16.13%)明显低于对照组(45.16%)(P<0.05)。结论:脓毒性休克的患者采用主动脉内球囊反搏术的临床效果显著,明显改善了患者的血压、心率,使尿量增加,且不良事件发生少,安全有效。 Objective:To analyze clinical application of intra?aortic balloon pump in the treatment of septic shock.Methods:A total of 62 patients with septic shock in our hospital were assigned into the control group and the observation group according to digital table method, with 31 cases in each group. Patients in the control group were treated with conventional antishock method and patients in the observation group were given intra?aortic balloon pump therapy based on the treatment.Blood pressure, heart rate, urine volume and adverse event in the two groups were compared after treatment.Results:After treatment,blood pressure, heart rate and urine volume of the observation group were improved significantly compared with that in the control group (P〈0.05).The overall incidence of adverse events in the observation group (16.13%) was significantly lower than that in the control group (45.16%) after treatment (P〈0.05). Conclusion:Intra-aortic balloon pump therapy exerts obvious effect in the treatment of septic shock, significantly improves the patient??s blood pressure and heart rate, increases urine volume, causes less adverse events,and is safe and effective.
出处 《沈阳医学院学报》 2016年第4期265-266,共2页 Journal of Shenyang Medical College
关键词 脓毒性休克 主动脉内球囊反搏术 临床效果 septic shock intra-aortic balloon pump clinical effect
  • 相关文献

参考文献8

二级参考文献68

  • 1曲海,李艳.浅谈难治性脓毒症休克的临床特征和治疗特点[J].当代医药论丛,2014,12(1):136-137. 被引量:4
  • 2Pitsis AA, Visouli AN. Mechanical assistance of the circulationduring cardiogenic shock. Curr Opin Crit Care,2011,17 : 425-438.
  • 3Sayer GT, Baker JN, Parks KA. Heart rescue: the role of me-chanical circulatory support in the management of severe re-fractory cardiogenic shock. Curr Opin Crit Care,2012,18:409-416.
  • 4Valk SD, Cheng JM, den Uil CA, et al. Encouraging survivalrates in patients with acute myocardial infarction treated withan intra-aortic balloon pump. Neth Heart J ,2011 * 19 : 112-118.
  • 5BraunW,陈灏珠,译.心脏病学[M].第5版.北京:人民卫生出版社,2001:1119-1120.
  • 6Dellinger RP,Levy MM,Rhodes A. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Medicine,2013.165-228.
  • 7Dellinger RP,Levy MM,Rhodes A,et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2):165-228.
  • 8Kimmoun A,Ducrocg N,Levy B.Mechanisms of vascular hyporesponsiveness in septic shock[J].Curr Vasc Pharmacol,2013,11(2):139-149.
  • 9Bassi E,Park M,Azevedo LC.Therapeutic strategies for high-dose vasopressor-dependent shock[J].Crit Care Res Pract,2013,2013:654708.
  • 10Ducrocg N,Kimmoun A,Furmaniuk A,et al.Comparison of equipressor doses of norepinephrine,epinephrine,and phenylephrine on septic myocardial dysfunction[J].Anesthesiology,2012,116(5):1083-1091.

共引文献694

同被引文献53

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部